Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: Evidence for distinct pathways of gliomagenesis

Neuro-Oncology

Volumn 15, Issue 8, 2013, Pages 1041-1047

  Walsh, Kyle M ^a,b   Rice, Terri ^a   Decker, Paul A ^c   Kosel, Matthew L ^c   Kollmeyer, Thomas ^c   Hansen, Helen M ^a   Zheng, Shichun ^a   McCoy, Lucie S ^a   Bracci, Paige M ^a   Anderson, Erik ^a   Hsuang, George ^a   Wiemels, Joe L ^a   Pico, Alexander R ^d   Smirnov, Ivan ^e   Molinaro, Annette M ^a   Tihan, Tarik ^a   Berger, Mitchell S ^a   Chang, Susan M ^a   Prados, Michael D ^a   Lachance, Daniel H ^c   Sicotte, Hugues ^c   Eckel Passow, Jeanette E ^c   Wiencke, John K ^a   Jenkins, Robert B ^c   Wrensch, Margaret R ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic   (United States)

^d GLADSTONE INSTITUTES   (United States)

^e NONE

Author keywords

age at diagnosis; glioma; single nucleotide polymorphism; telomerase; telomere

Indexed keywords

TELOMERASE;

ADULT; ALLELE; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RISK; CARCINOGENESIS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; MALE; OLIGODENDROGLIOMA; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; TELOMERE HOMEOSTASIS; UNITED STATES;

AGE AT DIAGNOSIS; GLIOMA; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERASE; TELOMERE;

ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DNA HELICASES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880687549     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not051     Document Type: Article

References (30)

1. Stupp R, Hegi ME, Mason WP, et al. Effectsofradiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
2. Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg. 2011;115(5):948-965.
3. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905-908.
4. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
5. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011;20(14):2897-2904.
6. Stacey SN, Sulem P, Jonasdottir A, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 2011;43(11):1098-1103.
7. Bahuau M, Vidaud D, Jenkins RB, et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 1998;58(11):2298-2303. (Pubitemid 28252682)
8. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in afamilial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250(4985):1233-1238. (Pubitemid 120031831)
9. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factorreceptor geneinma-lignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987;84(19):6899-6903.
10. Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol. 2011;21(6):349-353.
11. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89(21):10114-10118.
12. Uringa EJ, Lisaingo K, Pickett HA, et al. RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol Biol Cell. 2012;23(14):2782-2792.
13. Sfeir A, Kosiyatrakul ST, Hockemeyer D, et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell. 2009;138(1):90-103.
14. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 1997;3(11): 1271-1274. (Pubitemid 27508830)
15. Jenkins RB, Xiao Y, Sicotte H, et al. A low-frequency 8q24.21 variant is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH mutation. Nat Genet. 2012;44(10):1122-1125.
16. Jenkins RB, Wrensch MR, Johnson D, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 2011;204(1):13-18.
17. Walsh KM, Anderson E, Hansen HM, et al. Analysisof60reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genet Epidemiol. 2013;37(2):222-228.
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
19. Christensen BC, Smith AA, Zheng S, et al. DNA methylation, isocitrate de-hydrogenase mutation, and survival in glioma. J Natl Cancer Inst. 2011;103(2):143-153.
20. Kipp BR, Voss JS, Kerr S E, et al. Isocitrate dehydrogenase1and2mutations in cholangiocarcinoma. Hum Pathol. 2012. Epub ahead of print.
21. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765-773.
22. Rice T, Zheng Z, Decker PA, Walsh KM, et al. Inherited variant on chromosome 11q23 increases susceptibility to IDH mutated but not IDH normal gliomas regardless of grade or histology. Neuro Oncol. 2013;15(5): 535-541.
23. Jiao Y, Killela PJ, Reitman ZJ, et al. Frequent ATRX, CIC, and FUBP1 mutations refine the classification of malignant gliomas. Oncotarget. 2012;3(7):709-722.
24. Heaphy CM, de Wilde RF, Jiao Y, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science. 2011;333(6041):425.
25. McDonald KL, McDonnell J, Muntoni A, et al. Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol. 2012;69(7):729-736.
26. Henson JD, Hannay JA, McCarthy SW, et al. Arobust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res. 2005;11(1):217-225. (Pubitemid 40075798)
27. Mangino M, Hwang SJ, Spector TD, et al. Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet. 2012;21(24):5385-5394.
28. Atzmon G, Cho M, Cawthon RM, et al. Evolutionin Health and Medicine Sackler Colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci U S A. 2010;107(Suppl 1):1710-1717.
29. Mocellin S, Verdi D, Pooley KA, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012;104(11):840-854.
30. The International HapMap Project. Nature. 2003;426(6968):789-796.